Core Insights - The establishment of the Fangchenggang International Medical Open Trial Zone plays a significant role in promoting international medical innovation cooperation among Shanghai Cooperation Organization (SCO) and ASEAN countries, contributing to the high-quality development of the Belt and Road Initiative [1][2] Group 1: Forum Overview - The 2025 International Medical Innovation Cooperation Forum was held in Fangchenggang, focusing on the theme "Medical Innovation Sharing for Sustainable Health Development" [2][3] - The forum featured speeches from various dignitaries, including the Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference, emphasizing the importance of deepening medical innovation cooperation with SCO and ASEAN countries [2][3] Group 2: Achievements and Collaborations - The forum resulted in the establishment of several collaborative initiatives, including the Mediterranean Thalassemia Prevention and Control Joint Innovation Center and a memorandum of cooperation between Guangxi University of Chinese Medicine and Kyrgyz State Medical Academy [3][4] - Participants discussed various topics such as international medical insurance policy exchange, healthcare and industry innovation, and the protection and utilization of medicinal resources, leading to a series of cooperation agreements [3][4] Group 3: Future Prospects - The successful hosting of the forum is expected to inject new momentum into Guangxi's pharmaceutical industry and create more development opportunities [4][5] - The Fangchenggang International Medical Open Trial Zone is seen as a crucial platform for international medical innovation cooperation, with expectations for further collaboration in areas like traditional medicine, modern healthcare, and artificial intelligence [5][7] Group 4: International Cooperation - The forum has been recognized as an important platform for international medical cooperation, gradually linking SCO, ASEAN, and Belt and Road Initiative countries [8][9] - There is a collective aspiration among participants to establish a health innovation platform under the SCO framework, promoting equitable access to innovative resources and standardizing digital healthcare and AI-assisted diagnosis [9]

Group 1: International Medical Cooperation Initiatives - The International Medical Innovation Cooperation Forum aims to promote international medical cooperation and build a global health community, with participation from Shanghai Cooperation Organization (SCO) member states and ASEAN countries [1][2][4] - The establishment of the Fangchenggang International Medical Open Trial Zone serves as a significant platform for international medical innovation cooperation, supported by the SCO [2][3] - The third International Medical Innovation Cooperation Forum in November 2023 resulted in the signing of 25 projects with a total investment of 21.9 billion yuan, covering various fields including healthcare and pharmaceutical manufacturing [4] Group 2: Economic Impact and Investment - The 2021 International Medical Innovation Cooperation Forum led to the signing of 13 projects with a total investment of 7.479 billion yuan, focusing on medical innovation and traditional medicine development [3] - The Guangxi region has seen a 50.2% year-on-year increase in medical device exports in the first quarter of 2023, indicating a strong growth trajectory in the medical device industry [8] - The establishment of the China-ASEAN Medical Equipment Industry Alliance aims to enhance market access for medical device companies in ASEAN countries [7] Group 3: Cross-Border Medical Services - The "1369 Life Green Channel" is a cross-border medical rescue service established between China and Vietnam, facilitating timely medical assistance for patients across borders [10][11] - This initiative has successfully treated over 650 patients, showcasing the effectiveness of cross-border medical cooperation [11] - The Guangxi region plans to replicate the success of the "1369 Life Green Channel" with more SCO member states and ASEAN countries to enhance cross-border medical collaboration [11]